Skip to content

PrEP doesn't lead to increases in risky sex among gay men

Monthly injectable drug offers 100% protection against HIV in monkeys – could be dosed every three months

Chasity Andrews, of the Aaron Diamond AIDS Research Center, presenting at CROI 2013.

VOICE trial: disappointing result poses big questions for PrEP

Jeanne Marrazzo discusses results of the VOICE study at CROI 2013. © Liz Highleyman / hivandhepatitis.com

US gay youth PrEP study meets recruitment and adherence problems

PrEP wars: debating pre-exposure prophylaxis in the gay community

Tenofovir impairs enzyme that stops cells ageing

Recreational drug use associated with non-prescription use of HIV PrEP among gay men in Australia

Some sexual lubricants damage cells – but may not increase HIV risk

"How are we going to have a baby? I’m positive and you’re not"